Highest dose of a drug that does not produce a significant increase in adverse effects in comparison to a control group in clinical (human) or preclinical studies (animal).

Calculating NOAELs is an important aspect of risk assessment in drug development. Determining NOAEL values informs the choice of dose used in clinical trials.